Nautilus Biotechnology, Inc. Stock News

On Friday's episode of "Mad Money," host Jim Cramer reviewed the investment cases for Nautilus Biotechnology and Cyxtera Technologies, two companies that viewers had previously called about in search

Nautilus operates in the field of Proteomics, a $25 billion market, growing at 12% per year.

Are these on your list of penny stocks to buy this week? The post Penny Stocks To Buy This Week: 4 To Watch Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.c

Nautilus Biotechnology, Inc. (NAUT) CEO Sujal Patel on Q3 2021 Results - Earnings Call Transcript

SEATTLE, Oct. 11, 2021 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome

SEATTLE, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the human p

Nautilus Biotechnology seeks to deliver on the untapped potential of the human proteome.

Nautilus Biotechnology's (NAUT) CEO Sujal Patel on Q2 2021 Results - Earnings Call Transcript

SEATTLE, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a life sciences company creating a platform technology for quantifying and unlocking the comp

Nautilus Biotechnology Inc (NASDAQ: NAUT) shares are trading higher during mid-day trading on Thursday following a CNBC report that Amazon.com Inc (NASDAQ: AMZN) held around $15 million stake in

Nautilus is developing a platform that works to measure and identify the complexities of proteins, which could lead to drug discoveries.

Shares of Nautilus Biotechnology rose by as much as 50% on Thursday morning after a report revealed that Amazon has taken an equity stake in the newly public Seattle-based company.

CNBC's Dominic Chu reports on an Amazon invetment of $14.7 million in Nautilus, a pre-revenue biotech firm.